Neurocrine Biosciences Inc NBIX
10 insiders sold $24.8M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $65.0M sold on 21 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Julie Cooke Chief Human Resources Officer |
- | $5.8M | Jun 2, 2026 |
| Stephen A. Sherwin Director |
- | $4.1M | Jun 5, 2026 |
| Ingrid Delaet Chief Regulatory Officer |
- | $3.7M | Jul 10, 2026 |
| Darin Lippoldt Chief Legal Officer |
- | $3.5M | Jul 9, 2026 |
| Jude Onyia Chief Scientific Officer |
- | $3.5M | Jun 1, 2026 |
| George J. Morrow Director |
- | $2.3M | Nov 3, 2026 |
| David W. Boyer Chief Corp. Affairs Officer |
- | $739K | Sep 14, 2026 |
| Leslie V. Norwalk Director |
- | $438K | Jul 28, 2026 |
| Matt Abernethy Chief Financial Officer |
- | $363K | Sep 14, 2026 |
| Eric Benevich Chief Commercial Officer |
- | $333K | Sep 9, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 39 open-market sales by officers and directors, 7 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -100 | 16K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -100 | 16K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -600 | 98K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -1,226 | 202K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -908 | 150K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -1,466 | 244K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -1,500 | 252K |
| Nov 3, 2026 | George J. Morrow | Sale (10b5-1) | -1,300 | 219K |
| Nov 2, 2026 | George J. Morrow | Sale (10b5-1) | -1,900 | 275K |
| Nov 2, 2026 | George J. Morrow | Sale (10b5-1) | -4,300 | 627K |
| Nov 2, 2026 | George J. Morrow | Sale (10b5-1) | -1,300 | 191K |
| Oct 30, 2026 | George J. Morrow | Sale (10b5-1) | -300 | 45K |
| Sep 14, 2026 | Matt Abernethy | Sale (10b5-1) | -2,311 | 363K |
| Sep 14, 2026 | David W. Boyer | Sale (10b5-1) | -826 | 130K |
| Sep 9, 2026 | Eric Benevich | Sale (10b5-1) | -2,154 | 333K |
| Jul 28, 2026 | Leslie V. Norwalk | Sale (10b5-1) | -1,250 | 228K |
| Jul 10, 2026 | Ingrid Delaet | Sale (10b5-1) | -4,367 | 791K |
| Jul 9, 2026 | Darin Lippoldt | Sale (10b5-1) | -10,000 | 1.8M |
| Jul 9, 2026 | Ingrid Delaet | Sale (10b5-1) | -8,433 | 1.5M |
| Jul 8, 2026 | Ingrid Delaet | Sale (10b5-1) | -2,737 | 489K |
| Jul 7, 2026 | Ingrid Delaet | Sale (10b5-1) | -3,401 | 607K |
| Jun 29, 2026 | Darin Lippoldt | Sale (10b5-1) | -8,110 | 1.4M |
| Jun 29, 2026 | Darin Lippoldt | Sale (10b5-1) | -1,690 | 289K |
| Jun 26, 2026 | Darin Lippoldt | Sale (10b5-1) | -200 | 34K |
| Jun 5, 2026 | Stephen A. Sherwin | Sale (10b5-1) | -7,883 | 1.3M |
| Jun 5, 2026 | Stephen A. Sherwin | Sale (10b5-1) | -2,549 | 419K |
| Jun 5, 2026 | Stephen A. Sherwin | Sale (10b5-1) | -6,896 | 1.1M |
| Jun 5, 2026 | Stephen A. Sherwin | Sale (10b5-1) | -5,829 | 971K |
| Jun 5, 2026 | Stephen A. Sherwin | Sale (10b5-1) | -1,843 | 308K |
| Jun 4, 2026 | Leslie V. Norwalk | Sale (10b5-1) | -1,250 | 210K |
| Jun 2, 2026 | Julie Cooke | Sale (10b5-1) | -14,214 | 2.2M |
| Jun 2, 2026 | Julie Cooke | Sale (10b5-1) | -5,466 | 850K |
| Jun 2, 2026 | Julie Cooke | Sale (10b5-1) | -4,216 | 661K |
| Jun 2, 2026 | Julie Cooke | Sale (10b5-1) | -9,521 | 1.5M |
| Jun 2, 2026 | Julie Cooke | Sale (10b5-1) | -3,520 | 558K |
| Jun 1, 2026 | Jude Onyia | Sale (10b5-1) | -11,000 | 1.8M |
| May 29, 2026 | Ingrid Delaet | Sale (10b5-1) | -2,261 | 354K |
| May 27, 2026 | Jude Onyia | Sale (10b5-1) | -11,000 | 1.7M |
| May 26, 2026 | David W. Boyer | Sale (10b5-1) | -3,888 | 609K |
Show the other 24 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NBIX/export.csv") into a cell.